Study of VB4-845 Injection for Treating Patients With Non-muscle Invasive Bladder Cancer
Clinical trial NCT04859751 · UNKNOWN
Trial details
- NCT number
- NCT04859751
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-23
- Primary completion
- 2022-06-01
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.